These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 18657017)

  • 1. Aspirin resistance: disparities and clinical implications.
    Airee A; Draper HM; Finks SW
    Pharmacotherapy; 2008 Aug; 28(8):999-1018. PubMed ID: 18657017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of aspirin in cardiovascular prevention: implications of aspirin resistance.
    Gasparyan AY; Watson T; Lip GY
    J Am Coll Cardiol; 2008 May; 51(19):1829-43. PubMed ID: 18466797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent.
    Zimmermann N; Gams E; Hohlfeld T
    Eur J Cardiothorac Surg; 2008 Jul; 34(1):93-108. PubMed ID: 18448350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of aspirin resistance.
    Patel D; Moonis M
    Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):969-75. PubMed ID: 17867925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of increased aspirin dose versus combined aspirin plus clopidogrel therapy in patients with diabetes mellitus and coronary heart disease and impaired antiplatelet response to low-dose aspirin.
    Duzenli MA; Ozdemir K; Aygul N; Soylu A; Tokac M
    Am J Cardiol; 2008 Aug; 102(4):396-400. PubMed ID: 18678294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of aspirin resistance in patients with type 2 diabetes.
    Fateh-Moghadam S; Plöckinger U; Cabeza N; Htun P; Reuter T; Ersel S; Gawaz M; Dietz R; Bocksch W
    Acta Diabetol; 2005 Jun; 42(2):99-103. PubMed ID: 15944844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes, vascular complications and antiplatelet therapy: open problems.
    Cerbone AM; Macarone-Palmieri N; Saldalamacchia G; Coppola A; Di Minno G; Rivellese AA
    Acta Diabetol; 2009 Dec; 46(4):253-61. PubMed ID: 19048181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin resistance and adverse clinical events in patients with coronary artery disease.
    Chen WH; Cheng X; Lee PY; Ng W; Kwok JY; Tse HF; Lau CP
    Am J Med; 2007 Jul; 120(7):631-5. PubMed ID: 17602938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin resistance and compliance with therapy.
    Dawson J; Quinn T; Rafferty M; Higgins P; Ray G; Lees KR; Walters MR
    Cardiovasc Ther; 2011 Oct; 29(5):301-7. PubMed ID: 20553280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug insight: aspirin resistance--fact or fashion?
    Patrono C; Rocca B
    Nat Clin Pract Cardiovasc Med; 2007 Jan; 4(1):42-50. PubMed ID: 17180149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent.
    Wang ZJ; Zhou YJ; Liu YY; Yu M; Shi DM; Zhao YX; Guo YH; Cheng WJ; Jia de A; Cao Z; Nie B; Ge HL; Yang SW; Yan ZX
    Thromb Res; 2009 May; 124(1):46-51. PubMed ID: 19041120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin resistance.
    Ashwin KA; Bairy KL; Vidyasagar S; Verma M; Prashanth CK; Sachidananda A
    Indian J Physiol Pharmacol; 2007; 51(2):109-17. PubMed ID: 18175654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin resistance.
    Tran HA; Anand SS; Hankey GJ; Eikelboom JW
    Thromb Res; 2007; 120(3):337-46. PubMed ID: 17241655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A current problem in atherothrombotic diseases--aspirin resistance: definition, mechanisms, determination with laboratory tests and clinical implications].
    Pamukçu B; Oflaz H; Nişanci Y
    Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():20-6. PubMed ID: 18160363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of aspirin dosage to clinical outcomes after percutaneous coronary intervention: observations from the Ottawa Heart Institute PCI Registry.
    So D; Cook EF; Le May M; Glover C; Williams W; Ha A; Davies R; Froeschl M; Marquis JF; O'Brien E; Labinaz M
    J Invasive Cardiol; 2009 Mar; 21(3):121-7. PubMed ID: 19258643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aspirin resistance].
    Yilmaz MB; Balbay Y; Korkmaz S
    Anadolu Kardiyol Derg; 2004 Mar; 4(1):59-62. PubMed ID: 15033621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy.
    Ben-Dor I; Kleiman NS; Lev E
    Am J Cardiol; 2009 Jul; 104(2):227-33. PubMed ID: 19576352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current evidence and clinical implications of aspirin resistance.
    Kasotakis G; Pipinos II; Lynch TG
    J Vasc Surg; 2009 Dec; 50(6):1500-10. PubMed ID: 19679423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin "resistance".
    Zimmermann N; Weber AA; Hohlfeld T
    Herz; 2008 Jun; 33(4):270-8. PubMed ID: 18581076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and risk factors for aspirin and clopidogrel resistance in patients with coronary artery disease or ischemic cerebrovascular disease.
    Kim H; Lee HK; Han K; Jeon HK
    Ann Clin Lab Sci; 2009; 39(3):289-94. PubMed ID: 19667414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.